Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance.

Abstract

Christian Lienhardt and colleagues discuss the importance of communication and coordination between regulators, researchers, and policy makers to ensure tuberculosis trials provide high-quality evidence for policy decisions.